Trevena (TRVN) Competitors $1.67 +0.01 (+0.60%) As of 02/21/2025 02:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends TRVN vs. APM, VRAX, CMND, SNGX, ONVO, ABVC, ALZN, FRTX, MAAQ, and CANFShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Aptorum Group (APM), Virax Biolabs Group (VRAX), Clearmind Medicine (CMND), Soligenix (SNGX), Organovo (ONVO), ABVC BioPharma (ABVC), Alzamend Neuro (ALZN), Fresh Tracks Therapeutics (FRTX), Mana Capital Acquisition (MAAQ), and Can-Fite BioPharma (CANF). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Aptorum Group Virax Biolabs Group Clearmind Medicine Soligenix Organovo ABVC BioPharma Alzamend Neuro Fresh Tracks Therapeutics Mana Capital Acquisition Can-Fite BioPharma Aptorum Group (NASDAQ:APM) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations. Which has more risk & volatility, APM or TRVN? Aptorum Group has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500. Comparatively, Trevena has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Do insiders and institutionals have more ownership in APM or TRVN? 3.8% of Aptorum Group shares are held by institutional investors. Comparatively, 13.6% of Trevena shares are held by institutional investors. 64.0% of Aptorum Group shares are held by insiders. Comparatively, 2.7% of Trevena shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, APM or TRVN? Aptorum Group has higher earnings, but lower revenue than Trevena. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K13.20-$2.83MN/AN/ATrevena$3.12M0.46-$40.29M-$47.04-0.04 Does the media refer more to APM or TRVN? In the previous week, Aptorum Group's average media sentiment score of 0.00 equaled Trevena'saverage media sentiment score. Company Overall Sentiment Aptorum Group Neutral Trevena Neutral Does the MarketBeat Community prefer APM or TRVN? Trevena received 575 more outperform votes than Aptorum Group when rated by MarketBeat users. Likewise, 69.14% of users gave Trevena an outperform vote while only 68.33% of users gave Aptorum Group an outperform vote. CompanyUnderperformOutperformAptorum GroupOutperform Votes4168.33% Underperform Votes1931.67% TrevenaOutperform Votes61669.14% Underperform Votes27530.86% Is APM or TRVN more profitable? Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A Trevena N/A N/A -119.55% Do analysts rate APM or TRVN? Trevena has a consensus target price of $5.00, suggesting a potential upside of 199.40%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than Aptorum Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptorum Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTrevena beats Aptorum Group on 7 of the 11 factors compared between the two stocks. Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.44M$7.06B$5.84B$9.14BDividend YieldN/A2.76%4.76%3.85%P/E RatioN/A2.9318.2614.95Price / Sales0.46281.18434.4770.76Price / CashN/A65.9238.4235.17Price / Book-0.156.717.644.65Net Income-$40.29M$138.11M$3.18B$245.69M7 Day Performance-7.73%-2.54%-1.95%-2.68%1 Month Performance-10.22%-2.00%-0.23%-2.16%1 Year Performance-88.24%-5.04%16.69%12.90% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevena0.8635 of 5 stars$1.67+0.6%$5.00+199.4%-88.2%$1.44M$3.12M0.0040APMAptorum Group0.5047 of 5 stars$1.19-0.8%N/A-38.1%$6.16M$430,000.000.0030Gap UpVRAXVirax Biolabs Group0.8513 of 5 stars$1.90+1.3%N/A+93.9%$6.15M$160,000.000.005CMNDClearmind MedicineN/A$1.41+0.7%N/A-27.9%$6.02MN/A-0.75N/AGap UpSNGXSoligenix1.2055 of 5 stars$2.39-2.8%N/A-79.1%$6.00M$840,000.00-0.3220News CoverageONVOOrganovo1.1238 of 5 stars$0.39+2.1%N/A-63.1%$5.93M$110,000.00-0.3620Earnings ReportABVCABVC BioPharma1.1387 of 5 stars$0.46+8.9%N/A-41.2%$5.93M$150,000.00-0.5330News CoveragePositive NewsGap DownHigh Trading VolumeALZNAlzamend Neuro2.6053 of 5 stars$1.09+0.9%$32.00+2,835.8%-88.9%$5.92MN/A0.004Gap UpFRTXFresh Tracks TherapeuticsN/A$0.93-0.3%N/A-1.1%$5.55M$8.01M-0.6620MAAQMana Capital AcquisitionN/A$0.67-1.2%N/A-72.6%$5.44MN/A0.001High Trading VolumeCANFCan-Fite BioPharma1.9392 of 5 stars$1.53+1.0%$14.00+818.0%-11.7%$5.40M$740,000.00-0.858Analyst Forecast Related Companies and Tools Related Companies APM Alternatives VRAX Alternatives CMND Alternatives SNGX Alternatives ONVO Alternatives ABVC Alternatives ALZN Alternatives FRTX Alternatives MAAQ Alternatives CANF Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TRVN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
